Abstract
Introduction

GBS, characterized by acute flaccid paralysis and areflexia, is a prototypical post-infectious autoimmune disease. Most GBS patients have gastrointestinal or upper respiratory symptoms 1-3 weeks prior to the onset of limb weakness. Motor strength usually reaches its nadir within 4 weeks (1). Campylobacter jejuni (C. jejuni), cytomegalovirus, and Epstein-Barr virus have all been implicated frequently in the pathogenesis of GBS. Here, we report a 76-year-old woman who developed rapidly progressive GBS with high titers of IgG antibodies to GM1 and GalNAc-GD1a, 18 days after sustaining urosepsis due to Escherichia coli (E. coli). GBS preceded by E. coli urosepsis has not been previously reported.
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Serum obtained 2 days after the neurological onset was analyzed for IgG and IgM antibodies to gangliosides GM1, GM1b, GD1a, GalNAc-GD1a, GD1b, GT1a, and GQ1b by enzyme-linked immunosorbent assay as described elsewhere with minor modifications (2) . Absorbance 
Discussion
This case documents the development of post-infectious autoimmune polyneuropathy, which occurred after an infection that does not normally have this consequence. Our differential diagnosis included the critical illness polyneuropathy (3). Her onset of weakness was explosive, and her symptoms were more severe than typical GBS, but the history, physical examination and laboratory data were nonetheless compatible with GBS. Her ascending muscular weakness was notably symmetric, and albumino-cytologic dissociation was present in the CSF. Two-thirds of patients with GBS have antecedent respiratory or gastrointestinal symptoms. GBS has been reported in the setting of systemic diseases such as sarcoidosis, systemic lupus erythematosus (SLE) and lymphoma (4). C. jejuni, cytomegalovirus and Epstein-Barr virus have been frequently implicated in the pathogenesis of GBS, as have
